Suppr超能文献

I型多发性内分泌腺瘤病中增生性甲状旁腺的核DNA分析

Nuclear DNA analysis of hyperplastic parathyroid glands in multiple endocrine neoplasia type I.

作者信息

Komatsu M, Nishiyama R H, Bagwell C B

机构信息

Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.

出版信息

Arch Surg. 1992 Dec;127(12):1430-4. doi: 10.1001/archsurg.1992.01420120064012.

Abstract

Twenty-four hyperplastic parathyroid glands from 11 patients with multiple endocrine neoplasia type I (MEN-I), and 36 hyperplastic parathyroid glands in 15 patients with sporadic primary hyperparathyroidism, ie, not associated with MEN, were analyzed for DNA by flow cytometry. Sixteen of 24 hyperplastic parathyroid glands from patients with MEN-I were DNA diploid, and eight were DNA aneuploid. Thirty-three of 36 hyperplastic parathyroid glands from patients without MEN were DNA diploid, and only three were DNA aneuploid. The mean percentage of 4c level (a measure of the G2M phase of the cell cycle) of DNA diploid hyperplastic parathyroid glands taken from patients with MEN-I was 8.1% +/- 4.5%, which is significantly higher than the 3.5% +/- 3.4% for those taken from patients without MEN. Our results show that there is a difference in nuclear DNA content between hyperplastic parathyroid glands in patients with MEN-I and those in patients without MEN.

摘要

对11例I型多发性内分泌腺瘤病(MEN-I)患者的24个增生性甲状旁腺以及15例散发性原发性甲状旁腺功能亢进患者(即不伴有MEN)的36个增生性甲状旁腺进行了流式细胞术DNA分析。MEN-I患者的24个增生性甲状旁腺中,16个为DNA二倍体,8个为DNA非整倍体。无MEN患者的36个增生性甲状旁腺中,33个为DNA二倍体,仅3个为DNA非整倍体。MEN-I患者的DNA二倍体增生性甲状旁腺的4c水平(细胞周期G2M期的一个指标)平均百分比为8.1%±4.5%,显著高于无MEN患者的3.5%±3.4%。我们的结果表明,MEN-I患者的增生性甲状旁腺与无MEN患者的增生性甲状旁腺在核DNA含量上存在差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验